Close

Cantor Fitzgerald Reiterates Overweight Rating. $15 Price Target on ContraFect (CFRX), "Expect Upwards Earnings Revision to Move Share Higher"

May 16, 2022 9:49 AM EDT Send to a Friend
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $15.00 price target on ContraFect Corp. (NASDAQ: CFRX), following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login